Michela Noseda is Lecturer of Cardiac Molecular Pathology at the National Heart and Lung Institute.
Dr Noseda is PI of the international consortium funded by BHF/DZHK aiming to define the molecular and cellular drivers of heart failure, a co-PI in the consortium funded by CZI aiming to build a human heart cell atlas and is a co-lead of the Heart Biological Network within the space of the Human Cell Atlas.
How did I get here?
Dr Noseda received her medical training at the Universita' Cattolica del Sacro Cuore in Rome Italy. Here, she also established the fundamentals of her molecular and cellular biology training. She has subsequently moved with Dr Anna Lasorella and Dr Antonio iavarone at Albert Einstein College of Medicine (NY, USA) thanks to a fellowship (Borsa di studio Beatrice Angelini) and at the University of British Columbia where she was awarded three fellowships from the Canadian Institute of Health Research, Michael Smith Foundation for Health Research and Fondazione Italiana Ricerca sul Cancro) under the supervision of Dr Aly Karsan. In this phase of research she studied paediatric cancer and angiogenesis. During studies on vascular development Dr Noseda discovered an important role for the Notch family of proteins in cardiac development. This critical phase of her training prompted the need to further her experience in cardiac development and cardiac disease in one of the top cardiac science laboratories in the world, joining Professor Michael Schneider’s group at Baylor College of Medicine (Houston Texas, US) where she initiated her work on adult cardiac progenitors which was continued in the UK at Imperial College London. Dr Noseda has subsequently established her research group at Imperial College.
et al., 2021, Lack of evidence of ACE2 expression and replicative infection by SARSCoV-2 in human endothelial cells, Circulation, Vol:143, ISSN:0009-7322, Pages:865-868
et al., 2021, Decoding Covid-19 with the SARS-CoV-2 Genome, Current Genetic Medicine Reports, Vol:9, Pages:1-12
et al., 2020, Cells of the adult human heart, Nature, Vol:588, ISSN:0028-0836, Pages:466-472
et al., 2020, Human pluripotent stem cell-derived cardiomyocytes as a targetplatform for paracrine protection by cardiac mesenchymal stromalcells, Scientific Reports, Vol:10, ISSN:2045-2322
et al., 2020, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes., Nat Med, Vol:26, Pages:681-687